FIX vs NBIX · P/E 32, rev $9.10B vs P/E 45, rev $2.36B
Comfort Systems USA Inc (FIX) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Comfort Systems USA Inc (FIX) is a engineering & construction company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported FIX revenue for 2025-12-31 was $9.10B. Net income was $1.02B. Revenue was up 29.5% from 2024-12-31 to 2025-12-31. FIX currently screens at market cap $19.10B and trailing P/E 32.5.
Latest reported NBIX revenue for 2024-12-31 was $2.36B. Net income was $341.3M. Revenue was up 24.8% from 2023-12-31 to 2024-12-31. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
FIX currently screens at market cap $19.10B and trailing P/E 32.5. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the FIX and NBIX stock pages for the full models.
Not investment advice.